Differentiating among incretin therapies: a multiple-target approach to type 2 diabetes
Year: 2012
Type: review
Study design: Systematic Review
Author: S. Cornell
Institution: Midwestern University
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: type 2 diabetes, incretin-based therapy, GLP-1 receptor agonists, DPP-4 inhibitors, liraglutide, exenatide, HbA1c, fasting blood glucose, postprandial blood glucose, weight loss, beta-cell function, hypoglycemia, drug selection, combination therapy, obesity, hypertension, cardiovascular risk, drug safety
Open Access status: closed
Funder: Novo Nordisk
OpenAlex ID: W1919558603
